Neutral impactIPO
Manipal Health IPO subscribed 4.92x on final day; GMP slips to zero
Fortune India 3 hrs ago·31 Jul 2026, 1:25 pm
IPO Fortune India
The initial public offering (IPO) for Manipal Health Services received strong investor interest, with the issue being subscribed 4.92 times on the final day of bidding. This indicates robust demand from retail and institutional investors, suggesting confidence in the company's valuation and growth prospects. The subscription level reflects a healthy oversubscription, a positive sign for the issue's performance in the grey market.
Despite the strong subscription, the stock's grey market premium (GMP) has slipped to zero. This means the shares are currently trading at par with the issue price in the unofficial market. For investors, this suggests that the IPO is priced fairly and that the listing gains may be limited. The market is likely factoring in current market conditions and the company's financials into the current valuation.
Investors should watch the company's financial health, its competitive position in the healthcare sector, and the overall market sentiment ahead of the listing. The zero GMP indicates that the stock is not expected to see a significant jump on listing day. However, the strong subscription remains a key positive, showing that the IPO was well-received by the market.
Key takeaways
- Category: IPO.
Why it matters
A routine update. Use the price and stock snapshot to gauge how the market is responding.
